These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32634537)

  • 1. Stopping the routine use of contact precautions for management of MRSA and VRE at three academic medical centers: An interrupted time series analysis.
    Haessler S; Martin EM; Scales ME; Kang L; Doll M; Stevens MP; Uslan DZ; Pryor R; Edmond MB; Godbout E; Abbas S; Bearman G
    Am J Infect Control; 2020 Dec; 48(12):1466-1473. PubMed ID: 32634537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Discontinuing Contact Precautions for Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: An Interrupted Time Series Analysis.
    Bearman G; Abbas S; Masroor N; Sanogo K; Vanhoozer G; Cooper K; Doll M; Stevens MP; Edmond MB
    Infect Control Hosp Epidemiol; 2018 Jun; 39(6):676-682. PubMed ID: 29580304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discontinuing MRSA and VRE contact precautions: Defining hospital characteristics and infection prevention practices predicting safe de-escalation.
    Martin EM; Colaianne B; Bridge C; Bilderback A; Tanner C; Wagester S; Yassin M; Pontzer R; Snyder GM
    Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1595-1602. PubMed ID: 34847970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of Routine Contact Precautions for Endemic Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: A Retrospective Quasi-Experimental Study.
    Martin EM; Russell D; Rubin Z; Humphries R; Grogan TR; Elashoff D; Uslan DZ
    Infect Control Hosp Epidemiol; 2016 Nov; 37(11):1323-1330. PubMed ID: 27457254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninfectious Hospital Adverse Events Decline After Elimination of Contact Precautions for MRSA and VRE.
    Martin EM; Bryant B; Grogan TR; Rubin ZA; Russell DL; Elashoff D; Uslan DZ
    Infect Control Hosp Epidemiol; 2018 Jul; 39(7):788-796. PubMed ID: 29745356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
    Bardossy AC; Alsafadi MY; Starr P; Chami E; Pietsch J; Moreno D; Johnson L; Alangaden G; Zervos M; Reyes K
    Am J Infect Control; 2017 Dec; 45(12):1369-1371. PubMed ID: 28843943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconsidering contact precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
    Morgan DJ; Murthy R; Munoz-Price LS; Barnden M; Camins BC; Johnston BL; Rubin Z; Sullivan KV; Shane AL; Dellinger EP; Rupp ME; Bearman G
    Infect Control Hosp Epidemiol; 2015 Oct; 36(10):1163-72. PubMed ID: 26138329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can we reduce contact precautions days for methicillin-resistant Staphylococcus aureus and vancomycin resistant Enterococcus infected patients?
    Thottacherry ED; Hassoun A
    J Infect Public Health; 2020 Aug; 13(8):1118-1122. PubMed ID: 32336607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Contact Precautions to Prevent Transmission of Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci in Intensive Care Units.
    Khader K; Thomas A; Huskins WC; Stevens V; Keegan LT; Visnovsky L; Samore MH
    Clin Infect Dis; 2021 Jan; 72(Suppl 1):S42-S49. PubMed ID: 33512528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of contact precautions on falls, pressure ulcers and transmission of MRSA and VRE in hospitalized patients.
    Gandra S; Barysauskas CM; Mack DA; Barton B; Finberg R; Ellison RT
    J Hosp Infect; 2014 Nov; 88(3):170-6. PubMed ID: 25441487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term impact of contact precautions cessation for Methicillin-Resistant Staphylococcus Aureus (MRSA).
    AlMohanna Z; Snavely AC; Viviano JP; Bischoff WE
    Am J Infect Control; 2022 Mar; 50(3):336-341. PubMed ID: 34793891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discontinuation of contact precautions for methicillin-resistant
    Schrank GM; Snyder GM; Davis RB; Branch-Elliman W; Wright SB
    BMJ Qual Saf; 2020 Oct; 29(10):1-2. PubMed ID: 31320496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intervention to reduce transmission of resistant bacteria in intensive care.
    Huskins WC; Huckabee CM; O'Grady NP; Murray P; Kopetskie H; Zimmer L; Walker ME; Sinkowitz-Cochran RL; Jernigan JA; Samore M; Wallace D; Goldmann DA;
    N Engl J Med; 2011 Apr; 364(15):1407-18. PubMed ID: 21488763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multicenter Pragmatic Interrupted Time Series Analysis of Chlorhexidine Gluconate Bathing in Community Hospital Intensive Care Units.
    Dicks KV; Lofgren E; Lewis SS; Moehring RW; Sexton DJ; Anderson DJ
    Infect Control Hosp Epidemiol; 2016 Jul; 37(7):791-7. PubMed ID: 26861417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the removal of contact precautions for MRSA and VRE infected patients change health care-associated infection rate?: A systematic review and meta-analysis.
    Kleyman R; Cupril-Nilson S; Robinson K; Thakore S; Haq F; Chen L; Oyesanmi O; Browning K; Pino J; Mhaskar R
    Am J Infect Control; 2021 Jun; 49(6):784-791. PubMed ID: 33276000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hidden reservoir of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in patients newly admitted to an acute rehabilitation hospital.
    Rabinowitz RP; Kufera JA; Makley MJ
    PM R; 2012 Jan; 4(1):18-22. PubMed ID: 22269450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial.
    Climo MW; Sepkowitz KA; Zuccotti G; Fraser VJ; Warren DK; Perl TM; Speck K; Jernigan JA; Robles JR; Wong ES
    Crit Care Med; 2009 Jun; 37(6):1858-65. PubMed ID: 19384220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of colonization and infection with methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus and of Clostridium difficile infection in Canadian hospitals.
    Simor AE; Williams V; McGeer A; Raboud J; Larios O; Weiss K; Hirji Z; Laing F; Moore C; Gravel D;
    Infect Control Hosp Epidemiol; 2013 Jul; 34(7):687-93. PubMed ID: 23739072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Discontinuing Contact Precautions for VRE and MRSA on Device-Associated Infections.
    Edmond MB; Masroor N; Stevens MP; Ober J; Bearman G
    Infect Control Hosp Epidemiol; 2015 Aug; 36(8):978-80. PubMed ID: 25915205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuing Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) Is Associated With Rising VRE Bloodstream Infection Rates in Ontario Hospitals, 2009-2018: A Quasi-experimental Study.
    Johnstone J; Shing E; Saedi A; Adomako K; Li Y; Brown KA; Garber G
    Clin Infect Dis; 2020 Oct; 71(7):1756-1759. PubMed ID: 31922536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.